SCHEMBL24784904

SCHEMBL24784904

CN(/N=C/c1ccc(O)c(O)c1)c1nc(-c2ccccc2)cc(-c2ccccc2)n1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 9/20 1.00
▸ KMT2A Q03164 9/20 1.00
▸ LMNA P02545 5/20 1.00
▸ GAA P10253 1/20 1.00
▸ MAPT P10636 5/20 0.65
▸ PAX8 Q06710 1/20 0.65
▸ SMN1; SMN2 Q16637 3/20 0.47
▸ NPC1 O15118 1/20 0.47
▸ NFKB1 P19838 1/20 0.47
▸ RAB9A P51151 1/20 0.47
▸ NFKB2 Q00653 1/20 0.47
▸ RELA Q04206 1/20 0.47
▸ POLB P06746 3/20 0.47
▸ ALDH1A1 P00352 3/20 0.43
▸ KDM4E B2RXH2 2/20 0.43
▸ AURKA O14965 1/20 0.43
▸ AURKB Q96GD4 1/20 0.43
▸ BLM P54132 2/20 0.41
▸ L3MBTL1 Q9Y468 2/20 0.41
▸ ALPL P05186 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19736310 1.00 MEN1 (1.00) MEN1KMT2ALMNAGAAMAPT
SCHEMBL26134268 1.00 MEN1 (1.00) MEN1KMT2ALMNAGAAMAPT
SCHEMBL30548101 1.00 MEN1 (1.00) MEN1KMT2ALMNAGAAMAPT
SCHEMBL30082651 1.00 MEN1 (1.00) MEN1KMT2ALMNAGAAMAPT
SCHEMBL5592951 0.88 MEN1 (0.79) MEN1KMT2ALMNAGAAMAPT
SCHEMBL20609230 0.87 GAA (0.77) MEN1KMT2ALMNAGAAMAPT
SCHEMBL20609226 0.87 MEN1 (0.77) MEN1KMT2ALMNAGAAMAPT
SCHEMBL20609224 0.87 MEN1 (0.77) MEN1KMT2ALMNAGAAMAPT
SCHEMBL20609231 0.87 GAA (0.77) MEN1KMT2ALMNAGAAMAPT
SCHEMBL19736309 0.87 GAA (0.77) MEN1KMT2ALMNAGAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023187791-A1 TREATMENT OF VIRAL INFECTIONS RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2023-10-05 — — WO disclosed
WO-2022265950-A1 EGFR INHIBITOR AND PERK ACTIVATOR IN COMBINATION THERAPY AND THEIR USE FOR TREATING CANCER GENENTECH, INC. (US) 2022-12-22 — — WO disclosed
Send feedback